Virstatin
Product Specifications
UNSPSC Description
Virstatin inhibits the pili system synthesis and prevents A. baumannii biofilm formation. Virstatin also inhibits dimerization of the transcriptional activator ToxT[1][2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/virstatin.html
Purity
98.00
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(N(C1=O)CCCC(O)=O)C2=CC=CC3=CC=CC1=C23
Molecular Weight
283.283
References & Citations
[1]Nait Chabane Y, et al. Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii. BMC Microbiol. 2014 Mar 12;14:62.|[2]Shakhnovich EA, et al. Virstatin inhibits dimerization of the transcriptional activator ToxT. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2372-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-127041/Virstatin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-127041/Virstatin-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
88909-96-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
